The Swiss biotech sector proved robust growth in 2023. Revenues in 2023 increased by CHF500m to CHF7.3bn....
Up To Date
Latest News
Ipsen SA and RNA splicing modifier specialist Skyhawk Therapeutics Inc have entered a US$1.8bn licencing...
French drug maker Seabelife SAS will use a €1.5m price money to develop a new dual-acting necroptosis blocker...
Waste based biosurfactants producer Amphistar BV has closed a €6m funding round led by the European Circular...
Vaccine maker Sumagen Co. Ltd has launched a cGMP manufacturing partnership with French Naobios SAS for...
Finnish Solar Foods Oy has started microbial production of its protein powder Solein in Factory 01, Solar...